Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for CRBU

Stock Name	Caribou Biosciences Inc
Ticker	CRBU(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US1420381089

Show aggregate CRBU holdings

News associated with CRBU

Cambridge Investment Research Advisors Inc. Makes New $559,000 Investment in Caribou Biosciences, Inc. (NASDAQ:CRBU): Cambridge Investment Research Advisors Inc. bought a new position in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) in the first quarter, Holdings Channel reports. The institutional investor bought 612,412 shares of the company’s stock, valued at approximately $559,000. Other hedge funds and other institutional investors have also modified their holdings of the company. US Bancorp […] - 2025-07-09 04:40:02
Caribou Biosciences, Inc. (NASDAQ:CRBU) Stock Holdings Boosted by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC boosted its holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 51.4% during the 1st quarter, Holdings Channel reports. The fund owned 124,889 shares of the company’s stock after acquiring an additional 42,395 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Caribou Biosciences were worth $114,000 as of […] - 2025-06-25 04:57:01
Nuveen Asset Management LLC Increases Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU): Nuveen Asset Management LLC raised its holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 23.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 330,831 shares of the company’s stock after purchasing an additional 63,096 shares during the period. Nuveen Asset […] - 2025-06-06 04:54:52
Barclays PLC Purchases 15,578 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU): Barclays PLC raised its position in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 12.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 145,417 shares of the company’s stock after acquiring an additional 15,578 shares during the quarter. Barclays PLC’s holdings in Caribou Biosciences […] - 2025-05-13 04:34:54
Comparing Caribou Biosciences (NASDAQ:CRBU) and Invizyne Technologies (NASDAQ:IZTC): Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and Invizyne Technologies (NASDAQ:IZTC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings. Institutional & Insider Ownership 77.5% of Caribou […] - 2025-05-08 02:04:51
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Russell Investments Group Ltd.: Russell Investments Group Ltd. lifted its holdings in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 859.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,909 shares of the company’s stock after purchasing an additional 21,416 shares during the quarter. Russell Investments Group Ltd.’s […] - 2025-04-28 04:42:57
Caribou Biosciences, Inc. (NASDAQ:CRBU) Given Consensus Recommendation of “Buy” by Brokerages: Caribou Biosciences, Inc. (NASDAQ:CRBU – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five analysts that are covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued a report on the stock in the […] - 2025-04-17 04:43:10
Head to Head Review: Caribou Biosciences (NASDAQ:CRBU) & Atyr PHARMA (NASDAQ:ATYR): Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and Atyr PHARMA (NASDAQ:ATYR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Valuation and Earnings This table compares Caribou […] - 2025-02-07 04:32:51

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) CRBU holdings

Date	Number of CRBU Shares Held	Base Market Value of CRBU Shares	Local Market Value of CRBU Shares	Change in CRBU Shares Held	Change in CRBU Base Value	Current Price per CRBU Share Held	Previous Price per CRBU Share Held
2026-01-15 (Thursday)	64,093	USD 99,985	USD 99,985	304	USD -2,715	USD 1.56	USD 1.61
2026-01-14 (Wednesday)	63,789	USD 102,700	USD 102,700	304	USD 1,759	USD 1.61	USD 1.59
2026-01-13 (Tuesday)	63,485	USD 100,941	USD 100,941	0	USD 635	USD 1.59	USD 1.58
2026-01-12 (Monday)	63,485	USD 100,306	USD 100,306	304	USD -4,574	USD 1.58	USD 1.65999
2026-01-09 (Friday)	63,181	USD 104,880	USD 104,880	456	USD -1,125	USD 1.65999	USD 1.69
2026-01-08 (Thursday)	62,725	USD 106,005	USD 106,005	0	USD -5,018	USD 1.69	USD 1.77
2026-01-07 (Wednesday)	62,725	USD 111,023	USD 111,023	304	USD 3,659	USD 1.77	USD 1.72
2026-01-06 (Tuesday)	62,421	USD 107,364	USD 107,364	0	USD 6,866	USD 1.72	USD 1.61
2026-01-05 (Monday)	62,421	USD 100,498	USD 100,498	0	USD 1,249	USD 1.61	USD 1.58999
2026-01-02 (Friday)	62,421	USD 99,249	USD 99,249	152	USD 241	USD 1.58999	USD 1.59
2025-12-31 (Wednesday)	62,269	USD 99,008	USD 99,008	0	USD 0	USD 1.59	USD 1.59

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRBU by Blackrock for IE00BDZVHG35

Show aggregate share trades of CRBU

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 304 1.630 1.550 1.558 USD 474 1.97
2026-01-14 BUY 304 1.620 1.580 1.584 USD 482 1.98
2026-01-12 BUY 304 1.650 1.520 1.533 USD 466 2.00
2026-01-09 BUY 456 1.730 1.640 1.649 USD 752 2.01
2026-01-07 BUY 304 1.800 1.695 1.706 USD 518 2.02
2026-01-02 BUY 152 1.600 1.540 1.546 USD 235 2.05
2025-12-30 BUY 152 1.650 1.580 1.587 USD 241 2.07
2025-12-23 SELL -884 1.720 1.630 1.639 USD -1,449 2.12 Profit of 423 on sale
2025-12-22 BUY 1,332 1.735 1.670 1.676 USD 2,233 2.13
2024-11-18 SELL -2,340 1.980 2.089 2.078 USD -4,863 2.18 Profit of 236 on sale
2024-11-08 SELL -156 2.680 2.950 2.923 USD -456 2.13 Loss of -123 on sale
2024-10-21 SELL -156 1.970 2.010 2.006 USD -313 0.00 Loss of -313 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	304	1.630	1.550	1.558	USD 474	1.97
2026-01-14	BUY	304	1.620	1.580	1.584	USD 482	1.98
2026-01-12	BUY	304	1.650	1.520	1.533	USD 466	2.00
2026-01-09	BUY	456	1.730	1.640	1.649	USD 752	2.01
2026-01-07	BUY	304	1.800	1.695	1.706	USD 518	2.02
2026-01-02	BUY	152	1.600	1.540	1.546	USD 235	2.05
2025-12-30	BUY	152	1.650	1.580	1.587	USD 241	2.07
2025-12-23	SELL	-884	1.720	1.630	1.639	USD -1,449	2.12 Profit of 423 on sale
2025-12-22	BUY	1,332	1.735	1.670	1.676	USD 2,233	2.13
2024-11-18	SELL	-2,340	1.980	2.089	2.078	USD -4,863	2.18 Profit of 236 on sale
2024-11-08	SELL	-156	2.680	2.950	2.923	USD -456	2.13 Loss of -123 on sale
2024-10-21	SELL	-156	1.970	2.010	2.006	USD -313	0.00 Loss of -313 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRBU

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	215,102	500	486,795	44.2%
2025-09-18	226,671	0	1,242,813	18.2%
2025-09-17	169,329	0	547,089	31.0%
2025-09-16	231,347	160	676,688	34.2%
2025-09-15	149,109	0	221,815	67.2%
2025-09-12	213,615	0	359,387	59.4%
2025-09-11	124,859	600	292,070	42.7%
2025-09-10	98,846	3,178	235,827	41.9%
2025-09-09	155,843	382	279,442	55.8%
2025-09-08	111,551	0	255,176	43.7%
2025-09-05	79,022	0	232,876	33.9%
2025-09-04	141,765	1,418	340,024	41.7%
2025-09-03	74,238	0	179,299	41.4%
2025-09-02	117,888	0	221,508	53.2%
2025-08-29	90,487	0	244,121	37.1%
2025-08-28	158,096	139	559,408	28.3%
2025-08-27	287,152	2,650	775,997	37.0%
2025-08-26	182,794	0	501,058	36.5%
2025-08-25	96,683	2,628	282,422	34.2%
2025-08-22	244,496	0	793,579	30.8%
2025-08-21	69,437	24,250	238,517	29.1%
2025-08-20	63,355	0	200,352	31.6%
2025-08-19	221,884	0	475,211	46.7%
2025-08-18	275,989	0	784,012	35.2%
2025-08-15	295,189	8,869	618,433	47.7%
2025-08-14	392,894	0	765,969	51.3%
2025-08-13	142,192	0	832,019	17.1%
2025-08-12	49,737	0	359,233	13.8%
2025-08-11	58,875	0	259,650	22.7%
2025-08-08	107,959	2,450	351,614	30.7%
2025-08-07	158,724	401	638,156	24.9%
2025-08-06	271,478	7,218	812,891	33.4%
2025-08-05	127,478	0	548,175	23.3%
2025-08-04	132,795	0	502,514	26.4%
2025-08-01	121,485	29	609,823	19.9%
2025-07-31	164,548	0	715,317	23.0%
2025-07-30	222,510	29,421	843,671	26.4%
2025-07-29	479,212	96,163	1,981,908	24.2%
2025-07-28	222,184	1,671	958,925	23.2%
2025-07-25	178,815	1,248	872,233	20.5%
2025-07-24	279,785	3,761	1,158,735	24.1%
2025-07-23	324,373	11,252	1,677,325	19.3%
2025-07-22	383,731	7,756	1,316,775	29.1%
2025-07-21	381,139	163	1,418,926	26.9%
2025-07-18	406,792	18,869	1,814,705	22.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE